Y. Terui
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Oncology 12
- Cancer Treatment and Pharmacology 2
- Viral-associated cancers and disorders 2
- Co-authors
- Hiroyuki Nojiri (1 shared paper)Kiyohiko Hatake (17 shared papers)Yusuke Furukawa (4 shared papers)Kengo Takeuchi (14 shared papers)Masaru Yokoyama (10 shared papers)Yuko Mishima (9 shared papers)Masatsugu Ohta (2 shared papers)Kumi Sakoe (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)Blood Cancer Journal (2 papers)Hematological Oncology (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- JapanUnited KingdomIndia
In The Last Decade
Y. Terui
27 papers receiving 675 citations
Peers
Comparison fields: 5 of 68
- Immunology 221
- Pathology and Forensic Medicine 183
- Oncology 208
- Genetics 75
- Immunology and Allergy 33
Countries citing papers authored by Y. Terui
This map shows the geographic impact of Y. Terui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Terui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Terui more than expected).
Fields of papers citing papers by Y. Terui
This network shows the impact of papers produced by Y. Terui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Terui. The network helps show where Y. Terui may publish in the future.
Co-authors
The 25 scholars most cited alongside Y. Terui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 178 | |
| 2 | 2010 | 88 | |
| 3 | 2008 | 67 | |
| 4 | 1994 | 54 | |
| 5 | 2008 | 46 | |
| 6 | 2000 | 41 | |
| 7 | Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells. | 1998 | 40 |
| 8 | 1996 | 31 | |
| 9 | 2017 | 22 | |
| 10 | 2009 | 20 | |
| 11 | 2011 | 18 | |
| 12 | NH2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivo. | 1999 | 17 |
| 13 | 2014 | 15 | |
| 14 | 2009 | 15 | |
| 15 | 2012 | 11 | |
| 16 | 1995 | 8 | |
| 17 | 2006 | 3 | |
| 18 | 1998 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2011 | 2 |
About Y. Terui
Y. Terui is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 687 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Cell Function and Interaction (3 papers), Multiple Myeloma Research and Treatments (3 papers), Galectins and Cancer Biology (2 papers), Cancer Treatment and Pharmacology (2 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (221 citations), Pathology and Forensic Medicine (183 citations), Oncology (208 citations), Genetics (75 citations) and Immunology and Allergy (33 citations). Y. Terui has collaborated with scholars based in Japan, United Kingdom and India. Frequent co-authors include Hiroyuki Nojiri, Kiyohiko Hatake, Yusuke Furukawa, Kengo Takeuchi, Masaru Yokoyama, Yuko Mishima, Masatsugu Ohta, Kumi Sakoe, Masaki Saito and Shunji Takahashi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood Cancer Journal, Hematological Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.